The Role of Thrombin and its Receptors in Epithelial Malignancies: Lessons from a Transgenic Mouse Model and Transcriptional Regulation

作者: Zaidoun Salah , Sorina Grisaru-Granovsky , Myriam Maoz , Beatrice Uziely , Irit Cohen

DOI: 10.1007/978-0-387-09637-7_10

关键词:

摘要: The otherwise well-orchestrated epithelial sheets are disrupted when they acquire the ability to overexpress prototype mammalian thrombin receptor, human protease-activated receptor-1 (hPar1). This is exhibited by down-regulation of cell–cell contacts and alterations in cell–matrix interactions. notion that hPar1 one a series genes part malignant program stems from studies indicating expression directly correlates with tumor metastasis time-limited physiological invasion placenta uterus decidua. Our transgenic mouse model tissue-targeted overexpression mammary glands exhibits phenotype hyperplasia, characterized dense network ductal side branching accelerated proliferation. exhibit increased levels wnt-4 -7b, striking stabilization β-catenin. novel association between nuclear β-catenin may provide key determinant molecular pathway oncogenicity. While studying properties biology we demonstrated its role as survival factor protects cells undergoing apoptosis. Withdrawal gene leads selective apoptosis especially young sprouting blood vessels, whereas mature vessels remain unaffected. We also evidence showing tumors enhanced transcriptional activity. evaluated on basis elicited run-on transcription rate highly metastatic vs. low (on background equal stability rates). Indeed, have shown Egr-1 induced prostate cancer. In addition, suppressor p53 acts target genes, regulating level context given tumor. It still remains determine profile individual fingerprints specific motifs bind panel factors, well which critically involved altering according type

参考文章(59)
Strumane K, Cornelisse C, Nollet F, Cleton-Jansen Am, Berx G, van Roy F, de Leeuw Wj, E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. ,vol. 13, pp. 1919- 1925 ,(1996)
Shaun R. Coughlin, Thrombin signalling and protease-activated receptors Nature. ,vol. 407, pp. 258- 264 ,(2000) , 10.1038/35025229
J. Cross, Z Werb, S. Fisher, Implantation and the placenta: key pieces of the development puzzle Science. ,vol. 266, pp. 1508- 1518 ,(1994) , 10.1126/SCIENCE.7985020
L. C. Yeoman, J. K. V. Willson, B. Long, M. G. Brattain, A. E. Levine, S. Chakrabarty, Heterogeneity of human colon carcinoma Cancer and Metastasis Reviews. ,vol. 3, pp. 177- 191 ,(1984) , 10.1007/BF00048384
Kathryn E. Bass, Donald Morrish, Iris Roth, Damyanti Bhardwaj, Robert Taylor, Yan Zhou, Susan J. Fisher, Human cytotrophoblast invasion is up-regulated by epidermal growth factor: Evidence that paracrine factors modify this process Developmental Biology. ,vol. 164, pp. 550- 561 ,(1994) , 10.1006/DBIO.1994.1223
Olga Genbacev, Tacey E.K. White, Claire E. Gavin, Richard K. Miller, Human trophoblast cultures: Models for implantation and peri-implantation toxicology Reproductive Toxicology. ,vol. 7, pp. 75- 94 ,(1993) , 10.1016/0890-6238(93)90072-F
Carmen S. Tellez, Darren W. Davis, Victor G. Prieto, Jeffrey E. Gershenwald, Marcella M. Johnson, Marya F. McCarty, Menashe Bar-Eli, Quantitative Analysis of Melanocytic Tissue Array Reveals Inverse Correlation between Activator Protein-2α and Protease-Activated Receptor-1 Expression during Melanoma Progression Journal of Investigative Dermatology. ,vol. 127, pp. 387- 393 ,(2007) , 10.1038/SJ.JID.5700539
P K Lala, B P Lee, G Xu, C Chakraborty, Human placental trophoblast as an in vitro model for tumor progression. Canadian Journal of Physiology and Pharmacology. ,vol. 80, pp. 142- 149 ,(2002) , 10.1139/Y02-006
Z Salah, S Haupt, M Maoz, L Baraz, V Rotter, T Peretz, Y Haupt, R Bar-Shavit, p53 controls hPar1 function and expression. Oncogene. ,vol. 27, pp. 6866- 6874 ,(2008) , 10.1038/ONC.2008.324